Vira Shield 6+VL5 (Canada)

This page contains information on Vira Shield 6+VL5 for veterinary use.
The information provided typically includes the following:
  • Vira Shield 6+VL5 Indications
  • Warnings and cautions for Vira Shield 6+VL5
  • Direction and dosage information for Vira Shield 6+VL5

Vira Shield 6+vl5

This treatment applies to the following species:
Manufacturer: Novartis

Bovine Rhinotracheitis-virus Diarrhea-parainfluenza 3-respiratory Syncytial Virus Vaccine

Killed Virus

Campylobacter Fetus-leptospira Canicola-grippotyphosa-hardjo-icterohaemorrhagiae-pomona Bacterin

For Use in Animals Only

Vira Shield 6+VL5 Indications

For use in healthy breeding cattle, including pregnant cows and heifers, as an aid in the prevention of diseases caused by infectious bovine rhinotracheitis (IBR), bovine virus diarrhea (BVD Type 1 and BVD Type 2), parainfluenza Type 3 (PI3), and bovine respiratory syncytial (BRSV) viruses and Campylobacter fetus, Leptospira canicola, grippotyphosa, hardjo, icterohaemorrhagiae, and pomona. Produced from non-cytopathic (BVD Type 1 and BVD Type 2) and cytopathic (BVD Type 1) isolates.

Adjuvant

Xtend® SP.

Directions

Shake well before using. Administer 5 mL subcutaneously 2-4 weeks prior to breeding. In accordance with Beef Quality Assurance guidelines, this product should be administered subcutaneously (under the skin) in the neck. Revaccinate with Vira Shield® 6 in 4-5 weeks. Revaccinate annually or as recommended by your veterinarian.

Precautions

Store out of direct sunlight at 2°-7°C (35°-45°F). DO NOT FREEZE. Use entire contents when first opened. Do not vaccinate within 60 days prior to slaughter. Transient swelling may occur at the site of injection. Milk reduction and transient depression may be observed in lactating dairy cows for 3-6 days following vaccination. Anaphylactic reactions may occur. Symptomatic treatment: Epinephrine. Contains amphotericin B, gentamicin, and thimerosal as preservatives.

U.S. Vet. License No. 303

Novartis Animal Health US, Inc.

© 2007 Novartis; Registered trademarks of Novartis AG.

Novartis Animal Health Canada Inc., Mississauga, Ontario, Canada L5N 1V9

1-800-387-6325

10 Doses

50 mL

307CA-01

50 Doses

250 mL

 

Nac No.

12310761
NOVARTIS ANIMAL HEALTH CANADA INC.
2000 ARGENTIA RD., SUITE 400, PLAZA 3, MISSISSAUGA, ON, L5N 1V9
Telephone:   800-387-6325
Order Desk:   800-387-6325
Fax:   905-567-0221
Fax Orders:   800-827-5782
Website:   www.ah.novartis.ca
Email:   ah.questions@novartis.com
Every effort has been made to ensure the accuracy of the Vira Shield 6+VL5 information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the Canadian product label or package insert.

Copyright © 2014 North American Compendiums. Updated: 2014-09-05

(web2)